Search Results - "Tréton, X."

Refine Results
  1. 1

    Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery by Mondot, S, Lepage, P, Seksik, P, Allez, M, Tréton, X, Bouhnik, Y, Colombel, J F, Leclerc, M, Pochart, P, Doré, J, Marteau, P

    Published in Gut (01-06-2016)
    “…Preventing postoperative recurrence after ileocolonic resection (ICR) for Crohn's disease (CD) is challenging. Defining the disturbances of the microbial…”
    Get more information
    Journal Article
  2. 2

    Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A by Messal, N., Fernandez, N., Dayot, S., Gratio, V., Nicole, P., Prochasson, C., Chantret, I., LeGuilloux, G., Jarry, A., Couvelard, A., Tréton, X., Voisin, T., Ogier-Denis, E., Couvineau, A.

    “…Orexins (orexin-A and orexin-B) are hypothalamic peptides that are produced by the same precursor and are involved in sleep/wake control, which is mediated by…”
    Get full text
    Journal Article
  3. 3

    Early ileal resection in Crohn's disease is not associated with severe long‐term outcomes: The ERIC study by Grellier, Nathan, Kirchgesner, Julien, Uzzan, Mathieu, Mclellan, Paul, Stefanescu, Carmen, Lefèvre, Jérémie H., Treton, Xavier, Panis, Yves, Sokol, Harry, Beaugerie, Laurent, Seksik, Philippe

    Published in Alimentary pharmacology & therapeutics (01-11-2024)
    “…Summary Background Early complicated Crohn's disease (CD) may require ileal resection as first‐line treatment. Aim To evaluate the long‐term outcomes of…”
    Get full text
    Journal Article
  4. 4

    Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease by Sokol, H, Polin, V, Lavergne-Slove, A, Panis, Y, Treton, X, Dray, X, Bouhnik, Y, Valleur, P, Marteau, P

    Published in Gut (01-09-2009)
    “…A previous study suggested that the presence of myenteric plexitis in the proximal resection margins could be predictive of early endoscopic recurrence after…”
    Get more information
    Journal Article
  5. 5

    Deep ulcers are associated with increased C-reactive protein in active ulcerative colitis by Rivière, P., Le Chevillier, A., Rullier, A., Marty, M., Schurr, E., Lapuyade, B., Célerier, B., Fernandez, B., Bessissow, T., Treton, X., Uzzan, M., Poullenot, F., Berger, A., Zerbib, F., Laharie, D.

    Published in Digestive and liver disease (01-09-2023)
    “…Increased C-reactive protein (CRP) is used to diagnose and predict response to treatment in acute severe ulcerative colitis (UC). To investigate the connection…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Traitement des fistules de la maladie de Crohn par infliximab by TRETON, X

    Published in Côlon & rectum (2008)
    “…Résumé: Situation: Les fistules entérocutanées sont des complications sévères de la maladie de Crohn et de traitement difficile. L’infliximab, anticorps…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Effect of appendicectomy on colonic inflammation and neoplasia in experimental ulcerative colitis by Harnoy, Y., Bouhnik, Y., Gault, N., Maggiori, L., Sulpice, L., Cazals-Hatem, D., Boudjema, K., Panis, Y., Ogier-Denis, E., Treton, X.

    Published in British journal of surgery (01-10-2016)
    “…Background Ulcerative colitis (UC) promotes cancer, and can be ameliorated by early appendicectomy for appendicitis. The aim of the study was to explore the…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    DOP76 Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent by Buisson, A, Nachury, M, Fumery, M, Guilmoteau, T, Leclerc, E, Altwegg, R, Serrero, M, Mathieu, N, Treton, X, Vuitton, L, Pereira, B, Amiot, A, Bouguen, G

    Published in Journal of Crohn's and colitis (21-01-2022)
    “…Abstract Background Several therapeutic options are now available in ulcerative colitis after anti-TNF failure, but no data compared hitherto tofacitinib and…”
    Get full text
    Journal Article
  17. 17

    National diagnostic and care protocols (NDCP) for hematopoietic stem cell transplantation in autoimmune diseases by Farge, D, Pugnet, G, Allez, M, Castilla-Llorente, C, Chatelus, E, Cintas, P, Faucher-Barbey, C, Labauge, P, Labeyrie, C, Lioure, B, Maria, A, Michonneau, D, Puyade, M, Talouarn, M, Terriou, L, Treton, X, Wojtasik, G, Zephir, H, Marjanovic, Z

    Published in La revue de medecine interne (16-01-2024)
    “…Hematopoietic stem cell transplantation (HSCT) for severe ADs was developed over the past 25years and is now validated by national and international medical…”
    Get full text
    Journal Article
  18. 18

    Prognosis of Lymphoma in Patients With Known Inflammatory Bowel Disease: A French Multicentre Cohort Study by Severyns, T, Kirchgesner, J, Lambert, J, Thieblemont, C, Amiot, A, Abitbol, V, Treton, X, Cazals-Hatem, D, Malamut, G, Coppo, P, Galicier, L, Walter-Petrich, A, Deau-Fischer, B, Besson, C, Aparicio, T, Beaugerie, L, Allez, M, Gornet, J M

    Published in Journal of Crohn's and colitis (16-09-2020)
    “…Abstract Background and Aims The prognosis of lymphoma that occurs in patients with inflammatory bowel disease [IBD] is poorly known. Methods A multicentre…”
    Get full text
    Journal Article
  19. 19

    Is abdominal CT useful for the management of patients with severe acute colitis complicating inflammatory bowel disease? A study in 54 consecutive patients by Mege, D., Monsinjon, M., Zappa, M., Stefanescu, C., Treton, X., Maggiori, L., Bouhnik, Y., Panis, Y.

    Published in Colorectal disease (01-04-2017)
    “…Aim To evaluate the contribution of CT for the management of patients with severe acute exacerbation of colitis (SAC) complicating inflammatory bowel disease…”
    Get full text
    Journal Article
  20. 20

    Immunité et Maladies Inflammatoires Chroniques de l’Intestin (MICI) by Treton, X.

    Published in Côlon & rectum (01-11-2015)
    “…Résumé Les Maladies Inflammatoires Chroniques de l’Intestin (MICI) résultent d’une réponse immune non contrôlée face à des facteurs environnementaux non…”
    Get full text
    Journal Article